Review



control non targeting sirna  (Santa Cruz Biotechnology)


Bioz Verified Symbol Santa Cruz Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Santa Cruz Biotechnology control non targeting sirna
    Control Non Targeting Sirna, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 6194 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/non+targeting+control+sirna/pm41895783-62-4-10?v=Santa+Cruz+Biotechnology
    Average 96 stars, based on 6194 article reviews
    control non targeting sirna - by Bioz Stars, 2026-08
    96/100 stars

    Images



    Similar Products

    86
    System Biosciences Inc non targeting control sirna sinc
    Effects of TDO2 silencing in primary LSMC. Cells were transfected with siTDO2 or control <t>siRNA</t> <t>(siNC)</t> for 96 h, followed by assessment of gene expression by qRT-PCR. Expression levels of TDO2, VDR, MMP11, MMP14, COL11A1, CBX4, LINC02568, LINC01310, LINC02544, LINC02182, and miR-584-5p are shown. Data represent mean ± SEM from four independent experiments ( n = 4). Statistical significance is indicated as * P <0.05 and *** P <0.01.
    Non Targeting Control Sirna Sinc, supplied by System Biosciences Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/non+targeting+control+sirna/pmc13212361-65-14-28?v=System+Biosciences+Inc
    Average 86 stars, based on 1 article reviews
    non targeting control sirna sinc - by Bioz Stars, 2026-08
    86/100 stars
      Buy from Supplier

    86
    Sangon Biotech non targeting negative control sirna
    SNARE protein knockdown verification and colocalization analysis with glycoRNA. ( A ) Relative mRNA expression of v-SNARE protein after <t>siRNA-mediated</t> knockdown was determined by quantitative real-time PCR (qPCR). ( B ) Protein expression levels of v-SNARE protein were detected by Western blot. ( C ) Quantitative analysis of Western blot result( B ). ( D ) Relative mRNA expression of t-SNARE protein after siRNA-mediated knockdown was determined by quantitative real-time PCR (qPCR). ( E ) Protein expression levels of t-SNARE protein were detected by Western blot. ( F ) Quantitative analysis of Western blot result ( E ). Data are presented as mean ± SD ( n = 3). ( G ) Co-localization of t-SNARE (TSNARE1 channel) and v-SNARE (VTI1B channel) with GLINT-labeled glycoRNAs in the images (FAM channel). ( H ) The plot profiles show co-localization of glycoRNAs with t-SNARE or v-SNARE.
    Non Targeting Negative Control Sirna, supplied by Sangon Biotech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/non+targeting+control+sirna/pmc13122174-90-11-18?v=Sangon+Biotech
    Average 86 stars, based on 1 article reviews
    non targeting negative control sirna - by Bioz Stars, 2026-08
    86/100 stars
      Buy from Supplier

    95
    OriGene non targeting scrambled shrna
    SNARE protein knockdown verification and colocalization analysis with glycoRNA. ( A ) Relative mRNA expression of v-SNARE protein after <t>siRNA-mediated</t> knockdown was determined by quantitative real-time PCR (qPCR). ( B ) Protein expression levels of v-SNARE protein were detected by Western blot. ( C ) Quantitative analysis of Western blot result( B ). ( D ) Relative mRNA expression of t-SNARE protein after siRNA-mediated knockdown was determined by quantitative real-time PCR (qPCR). ( E ) Protein expression levels of t-SNARE protein were detected by Western blot. ( F ) Quantitative analysis of Western blot result ( E ). Data are presented as mean ± SD ( n = 3). ( G ) Co-localization of t-SNARE (TSNARE1 channel) and v-SNARE (VTI1B channel) with GLINT-labeled glycoRNAs in the images (FAM channel). ( H ) The plot profiles show co-localization of glycoRNAs with t-SNARE or v-SNARE.
    Non Targeting Scrambled Shrna, supplied by OriGene, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/non+targeting+control+sirna/pmc13004431-53-1-9?v=OriGene
    Average 95 stars, based on 1 article reviews
    non targeting scrambled shrna - by Bioz Stars, 2026-08
    95/100 stars
      Buy from Supplier

    86
    General Biosystems Inc non targeting control nc sirna duplexes
    SNARE protein knockdown verification and colocalization analysis with glycoRNA. ( A ) Relative mRNA expression of v-SNARE protein after <t>siRNA-mediated</t> knockdown was determined by quantitative real-time PCR (qPCR). ( B ) Protein expression levels of v-SNARE protein were detected by Western blot. ( C ) Quantitative analysis of Western blot result( B ). ( D ) Relative mRNA expression of t-SNARE protein after siRNA-mediated knockdown was determined by quantitative real-time PCR (qPCR). ( E ) Protein expression levels of t-SNARE protein were detected by Western blot. ( F ) Quantitative analysis of Western blot result ( E ). Data are presented as mean ± SD ( n = 3). ( G ) Co-localization of t-SNARE (TSNARE1 channel) and v-SNARE (VTI1B channel) with GLINT-labeled glycoRNAs in the images (FAM channel). ( H ) The plot profiles show co-localization of glycoRNAs with t-SNARE or v-SNARE.
    Non Targeting Control Nc Sirna Duplexes, supplied by General Biosystems Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/non+targeting+control+sirna/pmc13138745-406-12-22?v=General+Biosystems+Inc
    Average 86 stars, based on 1 article reviews
    non targeting control nc sirna duplexes - by Bioz Stars, 2026-08
    86/100 stars
      Buy from Supplier

    98
    Mirus Bio non targeting sirnas control
    SNARE protein knockdown verification and colocalization analysis with glycoRNA. ( A ) Relative mRNA expression of v-SNARE protein after <t>siRNA-mediated</t> knockdown was determined by quantitative real-time PCR (qPCR). ( B ) Protein expression levels of v-SNARE protein were detected by Western blot. ( C ) Quantitative analysis of Western blot result( B ). ( D ) Relative mRNA expression of t-SNARE protein after siRNA-mediated knockdown was determined by quantitative real-time PCR (qPCR). ( E ) Protein expression levels of t-SNARE protein were detected by Western blot. ( F ) Quantitative analysis of Western blot result ( E ). Data are presented as mean ± SD ( n = 3). ( G ) Co-localization of t-SNARE (TSNARE1 channel) and v-SNARE (VTI1B channel) with GLINT-labeled glycoRNAs in the images (FAM channel). ( H ) The plot profiles show co-localization of glycoRNAs with t-SNARE or v-SNARE.
    Non Targeting Sirnas Control, supplied by Mirus Bio, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/non+targeting+control+sirna/pm42023950-286-54-61?v=Mirus+Bio
    Average 98 stars, based on 1 article reviews
    non targeting sirnas control - by Bioz Stars, 2026-08
    98/100 stars
      Buy from Supplier

    86
    Sangon Biotech non targeting control sirna si control
    eIF4G2 post-transcriptionally sustains γc expression via its mRNA UTRs (A–C) Analysis in primary CD4 + CD8 lo transitional thymocytes. (A) Western blot analysis of γc and IL-7Rα protein levels. (B and C) Quantitative RT-PCR analysis of Il2rg (B) and Il7r (C) mRNA levels ( n = 3, ns p > 0.05, ∗ p < 0.05). (D–H) Mechanistic dissection in 293T cells. (D) Western blot of γc protein in control and EIF4G2 knockdown 293T cells transfected with an IL2RG coding sequence construct containing its native 5′ and 3′ UTRs. (E) Corresponding IL2RG mRNA levels measured by RT-qPCR ( n = 3, ns p > 0.05) . (F and G) Assessment of γc protein stability ( n = 3, ns p > 0.05). (F) Representative western blots and (G) quantification of γc protein levels over time following cycloheximide (CHX) treatment <t>in</t> <t>si-control</t> and si- EIF4G2 293T cells ( n = 3, ns p > 0.05). (H) Western blot of γc protein in si-control and si- EIF4G2 293T cells transfected with an IL2RG CDS construct lacking UTRs. Data are representative of at least two independent experiments. Bar graphs show mean ± SEM and unpaired Students’ t test was used to perform the statistical analysis.
    Non Targeting Control Sirna Si Control, supplied by Sangon Biotech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/non+targeting+control+sirna/pmc13049607-399-6-18?v=Sangon+Biotech
    Average 86 stars, based on 1 article reviews
    non targeting control sirna si control - by Bioz Stars, 2026-08
    86/100 stars
      Buy from Supplier

    86
    Sangon Biotech non targeting control sinc
    Knockdown of eIF3m suppressed FAdV-4 replication in vitro. (A and B) LMH cells transfected with siRNA targeting at eIF3m or <t>siNC</t> as a negative control were collected at 24 h for qRT-PCR (A) and at 48 h for western blot (B) to evaluate the knockdown effect. (C and D) LMH cells transfected with 100nM/well siRNA or siNC were infected with CH/HNJZ/2015 at an MOI of 0.01. Western blot (C) and virus titration (D) were analyzed to investigate virus growth kinetics. The data shown represent the means±SD, and the experiments were repeated three times. The statistics analysis was performed by 2-way ANOVA. *, P < 0.05, **, P < 0.01.
    Non Targeting Control Sinc, supplied by Sangon Biotech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/non+targeting+control+sirna/pmc12887161-69-14-21?v=Sangon+Biotech
    Average 86 stars, based on 1 article reviews
    non targeting control sinc - by Bioz Stars, 2026-08
    86/100 stars
      Buy from Supplier

    96
    Santa Cruz Biotechnology control non targeting sirna
    Knockdown of eIF3m suppressed FAdV-4 replication in vitro. (A and B) LMH cells transfected with siRNA targeting at eIF3m or <t>siNC</t> as a negative control were collected at 24 h for qRT-PCR (A) and at 48 h for western blot (B) to evaluate the knockdown effect. (C and D) LMH cells transfected with 100nM/well siRNA or siNC were infected with CH/HNJZ/2015 at an MOI of 0.01. Western blot (C) and virus titration (D) were analyzed to investigate virus growth kinetics. The data shown represent the means±SD, and the experiments were repeated three times. The statistics analysis was performed by 2-way ANOVA. *, P < 0.05, **, P < 0.01.
    Control Non Targeting Sirna, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/non+targeting+control+sirna/pm41895783-62-4-10?v=Santa+Cruz+Biotechnology
    Average 96 stars, based on 1 article reviews
    control non targeting sirna - by Bioz Stars, 2026-08
    96/100 stars
      Buy from Supplier

    96
    Addgene inc targeting control shrna
    Knockdown of eIF3m suppressed FAdV-4 replication in vitro. (A and B) LMH cells transfected with siRNA targeting at eIF3m or <t>siNC</t> as a negative control were collected at 24 h for qRT-PCR (A) and at 48 h for western blot (B) to evaluate the knockdown effect. (C and D) LMH cells transfected with 100nM/well siRNA or siNC were infected with CH/HNJZ/2015 at an MOI of 0.01. Western blot (C) and virus titration (D) were analyzed to investigate virus growth kinetics. The data shown represent the means±SD, and the experiments were repeated three times. The statistics analysis was performed by 2-way ANOVA. *, P < 0.05, **, P < 0.01.
    Targeting Control Shrna, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/non+targeting+control+sirna/pmc13011163-64-12-22?v=Addgene+inc
    Average 96 stars, based on 1 article reviews
    targeting control shrna - by Bioz Stars, 2026-08
    96/100 stars
      Buy from Supplier

    95
    OriGene non targeting scrambled shrna control
    ( A ) Western blot analysis showing expression of CHOP in control, S1P, and GSK pretreated S1P-treated CD8 + T cells. The adjacent bar graph depicts normalized densitometric data from three biological replicates ( n = 3). ( B ) q-PCR analysis of Ddit3 (encoding CHOP) in respective groups ( n = 3). ( C , D ) Western blot analysis showing expression of CHOP in activated CD8 + T cells upon S1pr1 knockdown using ( C ) siRNA and ( D ) <t>shRNA.</t> The adjacent bar graph depicts normalized densitometric data from three biological replicates ( N = 3, for both ( C , D ). ( E ) Purified mouse CD8⁺ T cells activated under the indicated treatment conditions were analyzed for the production of effector cytokines. The adjacent bar plots represent cumulative data from three biological replicates ( n = 3). ( F ) Purified mouse CD8⁺ T cells activated under the indicated treatment conditions were assessed for the frequency of CD8 + T cells undergoing apoptosis, as determined by Annexin V and 7AAD staining. The adjacent bar plots represent cumulative data from four biological replicates ( n = 4). ( G – L ) C57BL/6 mice ( n = 4 mice/group) with subcutaneously established YUMM1.7 melanoma tumor treated either with vehicle control or GSK, as ( G ) represented schematically, were evaluated for: ( H ) tumor growth, ( I ) the ability of CD8 + T cells from the tumor site to produce different effector cytokines, ( J ) frequency of CD8 + T cells at the tumor site, ( K ) expression of PD1, and ( L ) expression of Tim3 on intratumoral CD8 + T cells. * P < 0.05; ** P < 0.01; *** P < 0.005; **** P < 0.0001; ns, nonsignificant ( P > 0.05), the error bar represents the standard deviation (SD). P values are derived from unpaired two-tailed Student’s t test ( I – L ), one-way ANOVA ( A – F ), and two-way ANOVA test ( H ). .
    Non Targeting Scrambled Shrna Control, supplied by OriGene, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/non+targeting+control+sirna/pmc13121723-520-39-43?v=OriGene
    Average 95 stars, based on 1 article reviews
    non targeting scrambled shrna control - by Bioz Stars, 2026-08
    95/100 stars
      Buy from Supplier

    Image Search Results


    Effects of TDO2 silencing in primary LSMC. Cells were transfected with siTDO2 or control siRNA (siNC) for 96 h, followed by assessment of gene expression by qRT-PCR. Expression levels of TDO2, VDR, MMP11, MMP14, COL11A1, CBX4, LINC02568, LINC01310, LINC02544, LINC02182, and miR-584-5p are shown. Data represent mean ± SEM from four independent experiments ( n = 4). Statistical significance is indicated as * P <0.05 and *** P <0.01.

    Journal: Clinical Science (London, England : 1979)

    Article Title: In vivo inhibition of TDO2 in fibroids results in widespread alteration in the tumor transcriptome

    doi: 10.1042/CS20260395

    Figure Lengend Snippet: Effects of TDO2 silencing in primary LSMC. Cells were transfected with siTDO2 or control siRNA (siNC) for 96 h, followed by assessment of gene expression by qRT-PCR. Expression levels of TDO2, VDR, MMP11, MMP14, COL11A1, CBX4, LINC02568, LINC01310, LINC02544, LINC02182, and miR-584-5p are shown. Data represent mean ± SEM from four independent experiments ( n = 4). Statistical significance is indicated as * P <0.05 and *** P <0.01.

    Article Snippet: For gene silencing experiments, primary LSMCs were transfected with 50 nM of either a non-targeting control siRNA (siNC) or siRNA targeting TDO2 (siTDO2; 5′-CUAUCACUACCUGCGAUCAACUGUG-3′) using PureFection transfection reagent (System Biosciences, Mountain View, CA, U.S.A.), according to the manufacturer’s protocol.

    Techniques: Transfection, Control, Gene Expression, Quantitative RT-PCR, Expressing

    SNARE protein knockdown verification and colocalization analysis with glycoRNA. ( A ) Relative mRNA expression of v-SNARE protein after siRNA-mediated knockdown was determined by quantitative real-time PCR (qPCR). ( B ) Protein expression levels of v-SNARE protein were detected by Western blot. ( C ) Quantitative analysis of Western blot result( B ). ( D ) Relative mRNA expression of t-SNARE protein after siRNA-mediated knockdown was determined by quantitative real-time PCR (qPCR). ( E ) Protein expression levels of t-SNARE protein were detected by Western blot. ( F ) Quantitative analysis of Western blot result ( E ). Data are presented as mean ± SD ( n = 3). ( G ) Co-localization of t-SNARE (TSNARE1 channel) and v-SNARE (VTI1B channel) with GLINT-labeled glycoRNAs in the images (FAM channel). ( H ) The plot profiles show co-localization of glycoRNAs with t-SNARE or v-SNARE.

    Journal: Nucleic Acids Research

    Article Title: In situ tracking of glycoRNAs on single-cell surface to reveal RNA heterogeneity and transport mechanism

    doi: 10.1093/nar/gkag362

    Figure Lengend Snippet: SNARE protein knockdown verification and colocalization analysis with glycoRNA. ( A ) Relative mRNA expression of v-SNARE protein after siRNA-mediated knockdown was determined by quantitative real-time PCR (qPCR). ( B ) Protein expression levels of v-SNARE protein were detected by Western blot. ( C ) Quantitative analysis of Western blot result( B ). ( D ) Relative mRNA expression of t-SNARE protein after siRNA-mediated knockdown was determined by quantitative real-time PCR (qPCR). ( E ) Protein expression levels of t-SNARE protein were detected by Western blot. ( F ) Quantitative analysis of Western blot result ( E ). Data are presented as mean ± SD ( n = 3). ( G ) Co-localization of t-SNARE (TSNARE1 channel) and v-SNARE (VTI1B channel) with GLINT-labeled glycoRNAs in the images (FAM channel). ( H ) The plot profiles show co-localization of glycoRNAs with t-SNARE or v-SNARE.

    Article Snippet: siRNAs targeting human VTI1B, TSNARE1, and GAPDH, as well as a non-targeting negative control siRNA, were synthesized by Sangon Biotech (Shanghai, China).

    Techniques: Knockdown, Expressing, Real-time Polymerase Chain Reaction, Western Blot, Labeling

    eIF4G2 post-transcriptionally sustains γc expression via its mRNA UTRs (A–C) Analysis in primary CD4 + CD8 lo transitional thymocytes. (A) Western blot analysis of γc and IL-7Rα protein levels. (B and C) Quantitative RT-PCR analysis of Il2rg (B) and Il7r (C) mRNA levels ( n = 3, ns p > 0.05, ∗ p < 0.05). (D–H) Mechanistic dissection in 293T cells. (D) Western blot of γc protein in control and EIF4G2 knockdown 293T cells transfected with an IL2RG coding sequence construct containing its native 5′ and 3′ UTRs. (E) Corresponding IL2RG mRNA levels measured by RT-qPCR ( n = 3, ns p > 0.05) . (F and G) Assessment of γc protein stability ( n = 3, ns p > 0.05). (F) Representative western blots and (G) quantification of γc protein levels over time following cycloheximide (CHX) treatment in si-control and si- EIF4G2 293T cells ( n = 3, ns p > 0.05). (H) Western blot of γc protein in si-control and si- EIF4G2 293T cells transfected with an IL2RG CDS construct lacking UTRs. Data are representative of at least two independent experiments. Bar graphs show mean ± SEM and unpaired Students’ t test was used to perform the statistical analysis.

    Journal: iScience

    Article Title: Translation factor eIF4G2 directs CD8 + T cell lineage commitment by selectively enabling the IL-7 receptor response

    doi: 10.1016/j.isci.2026.115313

    Figure Lengend Snippet: eIF4G2 post-transcriptionally sustains γc expression via its mRNA UTRs (A–C) Analysis in primary CD4 + CD8 lo transitional thymocytes. (A) Western blot analysis of γc and IL-7Rα protein levels. (B and C) Quantitative RT-PCR analysis of Il2rg (B) and Il7r (C) mRNA levels ( n = 3, ns p > 0.05, ∗ p < 0.05). (D–H) Mechanistic dissection in 293T cells. (D) Western blot of γc protein in control and EIF4G2 knockdown 293T cells transfected with an IL2RG coding sequence construct containing its native 5′ and 3′ UTRs. (E) Corresponding IL2RG mRNA levels measured by RT-qPCR ( n = 3, ns p > 0.05) . (F and G) Assessment of γc protein stability ( n = 3, ns p > 0.05). (F) Representative western blots and (G) quantification of γc protein levels over time following cycloheximide (CHX) treatment in si-control and si- EIF4G2 293T cells ( n = 3, ns p > 0.05). (H) Western blot of γc protein in si-control and si- EIF4G2 293T cells transfected with an IL2RG CDS construct lacking UTRs. Data are representative of at least two independent experiments. Bar graphs show mean ± SEM and unpaired Students’ t test was used to perform the statistical analysis.

    Article Snippet: Cells were transfected either with a non-targeting control siRNA (si-Control) or human EIF4G2 targeting siRNA (si- EIF4G2 ) (Sangon Biotech) using Lipofectamine RNAiMAX transfection reagent (Invitrogen).

    Techniques: Expressing, Western Blot, Quantitative RT-PCR, Dissection, Control, Knockdown, Transfection, Sequencing, Construct

    Knockdown of eIF3m suppressed FAdV-4 replication in vitro. (A and B) LMH cells transfected with siRNA targeting at eIF3m or siNC as a negative control were collected at 24 h for qRT-PCR (A) and at 48 h for western blot (B) to evaluate the knockdown effect. (C and D) LMH cells transfected with 100nM/well siRNA or siNC were infected with CH/HNJZ/2015 at an MOI of 0.01. Western blot (C) and virus titration (D) were analyzed to investigate virus growth kinetics. The data shown represent the means±SD, and the experiments were repeated three times. The statistics analysis was performed by 2-way ANOVA. *, P < 0.05, **, P < 0.01.

    Journal: Poultry Science

    Article Title: eIF3m promotes fowl adenovirus serotype 4 replication via interacting with ORF1B protein

    doi: 10.1016/j.psj.2026.106566

    Figure Lengend Snippet: Knockdown of eIF3m suppressed FAdV-4 replication in vitro. (A and B) LMH cells transfected with siRNA targeting at eIF3m or siNC as a negative control were collected at 24 h for qRT-PCR (A) and at 48 h for western blot (B) to evaluate the knockdown effect. (C and D) LMH cells transfected with 100nM/well siRNA or siNC were infected with CH/HNJZ/2015 at an MOI of 0.01. Western blot (C) and virus titration (D) were analyzed to investigate virus growth kinetics. The data shown represent the means±SD, and the experiments were repeated three times. The statistics analysis was performed by 2-way ANOVA. *, P < 0.05, **, P < 0.01.

    Article Snippet: Based on the chicken eIF3m sequence obtained from GenBank, three siRNAs along with a non-targeting control (siNC) were synthesized by Shanghai Sangon Biotech.

    Techniques: Knockdown, In Vitro, Transfection, Negative Control, Quantitative RT-PCR, Western Blot, Infection, Virus, Titration

    ( A ) Western blot analysis showing expression of CHOP in control, S1P, and GSK pretreated S1P-treated CD8 + T cells. The adjacent bar graph depicts normalized densitometric data from three biological replicates ( n = 3). ( B ) q-PCR analysis of Ddit3 (encoding CHOP) in respective groups ( n = 3). ( C , D ) Western blot analysis showing expression of CHOP in activated CD8 + T cells upon S1pr1 knockdown using ( C ) siRNA and ( D ) shRNA. The adjacent bar graph depicts normalized densitometric data from three biological replicates ( N = 3, for both ( C , D ). ( E ) Purified mouse CD8⁺ T cells activated under the indicated treatment conditions were analyzed for the production of effector cytokines. The adjacent bar plots represent cumulative data from three biological replicates ( n = 3). ( F ) Purified mouse CD8⁺ T cells activated under the indicated treatment conditions were assessed for the frequency of CD8 + T cells undergoing apoptosis, as determined by Annexin V and 7AAD staining. The adjacent bar plots represent cumulative data from four biological replicates ( n = 4). ( G – L ) C57BL/6 mice ( n = 4 mice/group) with subcutaneously established YUMM1.7 melanoma tumor treated either with vehicle control or GSK, as ( G ) represented schematically, were evaluated for: ( H ) tumor growth, ( I ) the ability of CD8 + T cells from the tumor site to produce different effector cytokines, ( J ) frequency of CD8 + T cells at the tumor site, ( K ) expression of PD1, and ( L ) expression of Tim3 on intratumoral CD8 + T cells. * P < 0.05; ** P < 0.01; *** P < 0.005; **** P < 0.0001; ns, nonsignificant ( P > 0.05), the error bar represents the standard deviation (SD). P values are derived from unpaired two-tailed Student’s t test ( I – L ), one-way ANOVA ( A – F ), and two-way ANOVA test ( H ). .

    Journal: EMBO Reports

    Article Title: S1P-S1PR1 signaling impairs CD8 + T cell metabolism and effector function in tumors

    doi: 10.1038/s44319-026-00734-3

    Figure Lengend Snippet: ( A ) Western blot analysis showing expression of CHOP in control, S1P, and GSK pretreated S1P-treated CD8 + T cells. The adjacent bar graph depicts normalized densitometric data from three biological replicates ( n = 3). ( B ) q-PCR analysis of Ddit3 (encoding CHOP) in respective groups ( n = 3). ( C , D ) Western blot analysis showing expression of CHOP in activated CD8 + T cells upon S1pr1 knockdown using ( C ) siRNA and ( D ) shRNA. The adjacent bar graph depicts normalized densitometric data from three biological replicates ( N = 3, for both ( C , D ). ( E ) Purified mouse CD8⁺ T cells activated under the indicated treatment conditions were analyzed for the production of effector cytokines. The adjacent bar plots represent cumulative data from three biological replicates ( n = 3). ( F ) Purified mouse CD8⁺ T cells activated under the indicated treatment conditions were assessed for the frequency of CD8 + T cells undergoing apoptosis, as determined by Annexin V and 7AAD staining. The adjacent bar plots represent cumulative data from four biological replicates ( n = 4). ( G – L ) C57BL/6 mice ( n = 4 mice/group) with subcutaneously established YUMM1.7 melanoma tumor treated either with vehicle control or GSK, as ( G ) represented schematically, were evaluated for: ( H ) tumor growth, ( I ) the ability of CD8 + T cells from the tumor site to produce different effector cytokines, ( J ) frequency of CD8 + T cells at the tumor site, ( K ) expression of PD1, and ( L ) expression of Tim3 on intratumoral CD8 + T cells. * P < 0.05; ** P < 0.01; *** P < 0.005; **** P < 0.0001; ns, nonsignificant ( P > 0.05), the error bar represents the standard deviation (SD). P values are derived from unpaired two-tailed Student’s t test ( I – L ), one-way ANOVA ( A – F ), and two-way ANOVA test ( H ). .

    Article Snippet: Cells were maintained in complete DMEM (Gibco, Thermo Fisher Scientific) supplemented with:10% fetal bovine serum (FBS; Gibco), 1% penicillin–streptomycin (Gibco) For lentiviral production, HEK293T cells were co-transfected with: 15 μg lentiviral expression plasmid encoding S1pr1 shRNA, Eif2ak3 shRNA, or non-targeting scrambled shRNA control (Origene, USA) 10 μg psPAX2 packaging plasmid 5 μg pMD2.G envelope plasmid Transfection was carried out using the CaCl2/HBS precipitation method.

    Techniques: Western Blot, Expressing, Control, Knockdown, shRNA, Purification, Staining, Standard Deviation, Derivative Assay, Two Tailed Test

    ( A ) Western blot analysis of phospho-p38 (p-p38) and total p38 expression, in vehicle control and S1P-treated CD8 + T cells. The adjacent bar graph depicts normalized densitometric data from three biological replicates ( n = 3). ( B , C ) Western blot analysis showing the expression of p-p38 and total p38 in activated T cells upon S1pr1 knockdown using ( B ) siRNA ( n = 3) and (C) shRNA ( n = 3). The adjacent bar graph depicts normalized densitometric data. ( D ) Western blot analysis of p-p38 and total p38 in CD8 + T cells activated in the presence or absence of S1P, along with the indicated inhibitor. The adjacent bar graph depicts normalized densitometric data from three biological replicates ( n = 3). ( E , F ) qPCR analysis of transcript levels of different ( E ) Map3k and (F) Map2k genes in CD8 + T cells in respective groups ( n = 4). ( G ) CD8 + T cells were activated in the presence or absence of S1P and were collected and processed for chromatin-immunoprecipitation (ChIP) assay with an antibody specific for CHOP or with rabbit IgG control. qPCR primers specific for the known CHOP binding gene ( Dr5 ) and different Map3K and Map2K , along with Mapk14 , were used to determine CHOP binding to the respective promoters ( n = 4). ( H , I ) Purified mouse CD8⁺ T cells activated under the indicated treatment conditions were assessed for: ( H ) T cell death by Annexin V and 7AAD staining and ( I ) frequency of CD8 + T cells producing different effector cytokines. The adjacent bar represents cumulative data from four biological replicates ( n = 4, for both ( H , I )). ( J ) Extracellular flux assay for determining of oxygen consumption rate (OCR) in activated CD8 + T cells in respective groups. * P < 0.05; ** P < 0.01; *** P < 0.005; **** P < 0.0001; ns, nonsignificant ( P > 0.05), the error bar represents the standard deviation (SD). P values are derived from unpaired two-tailed Student’s t test ( A ), one-way ANOVA ( B – D , H , I ), and two-way ANOVA test ( E – G ). .

    Journal: EMBO Reports

    Article Title: S1P-S1PR1 signaling impairs CD8 + T cell metabolism and effector function in tumors

    doi: 10.1038/s44319-026-00734-3

    Figure Lengend Snippet: ( A ) Western blot analysis of phospho-p38 (p-p38) and total p38 expression, in vehicle control and S1P-treated CD8 + T cells. The adjacent bar graph depicts normalized densitometric data from three biological replicates ( n = 3). ( B , C ) Western blot analysis showing the expression of p-p38 and total p38 in activated T cells upon S1pr1 knockdown using ( B ) siRNA ( n = 3) and (C) shRNA ( n = 3). The adjacent bar graph depicts normalized densitometric data. ( D ) Western blot analysis of p-p38 and total p38 in CD8 + T cells activated in the presence or absence of S1P, along with the indicated inhibitor. The adjacent bar graph depicts normalized densitometric data from three biological replicates ( n = 3). ( E , F ) qPCR analysis of transcript levels of different ( E ) Map3k and (F) Map2k genes in CD8 + T cells in respective groups ( n = 4). ( G ) CD8 + T cells were activated in the presence or absence of S1P and were collected and processed for chromatin-immunoprecipitation (ChIP) assay with an antibody specific for CHOP or with rabbit IgG control. qPCR primers specific for the known CHOP binding gene ( Dr5 ) and different Map3K and Map2K , along with Mapk14 , were used to determine CHOP binding to the respective promoters ( n = 4). ( H , I ) Purified mouse CD8⁺ T cells activated under the indicated treatment conditions were assessed for: ( H ) T cell death by Annexin V and 7AAD staining and ( I ) frequency of CD8 + T cells producing different effector cytokines. The adjacent bar represents cumulative data from four biological replicates ( n = 4, for both ( H , I )). ( J ) Extracellular flux assay for determining of oxygen consumption rate (OCR) in activated CD8 + T cells in respective groups. * P < 0.05; ** P < 0.01; *** P < 0.005; **** P < 0.0001; ns, nonsignificant ( P > 0.05), the error bar represents the standard deviation (SD). P values are derived from unpaired two-tailed Student’s t test ( A ), one-way ANOVA ( B – D , H , I ), and two-way ANOVA test ( E – G ). .

    Article Snippet: Cells were maintained in complete DMEM (Gibco, Thermo Fisher Scientific) supplemented with:10% fetal bovine serum (FBS; Gibco), 1% penicillin–streptomycin (Gibco) For lentiviral production, HEK293T cells were co-transfected with: 15 μg lentiviral expression plasmid encoding S1pr1 shRNA, Eif2ak3 shRNA, or non-targeting scrambled shRNA control (Origene, USA) 10 μg psPAX2 packaging plasmid 5 μg pMD2.G envelope plasmid Transfection was carried out using the CaCl2/HBS precipitation method.

    Techniques: Western Blot, Expressing, Control, Knockdown, shRNA, Chromatin Immunoprecipitation, Binding Assay, Purification, Staining, XF Assay, Standard Deviation, Derivative Assay, Two Tailed Test

    ( A ) CD8⁺ T cells isolated from either the tumor site or spleen of C57BL/6 mice ( n = 4) bearing YUMM1.7 melanoma were assessed for p-p38 expression. The adjacent bar plot summarizes pooled data from four tumor-bearing mice. ( B ) Intratumoral CD8⁺ T cells from C57BL/6 mice ( n = 4/group) with subcutaneous YUMM1.7 melanoma, treated with vehicle control or p38i, were evaluated for the frequency of terminally exhausted CD8⁺ T cells (PD1⁺Tim3⁺). The adjacent bar plot summarizes pooled data from four mice per group. ( C ) Adoptively transferred Pmel-1 T cells transduced with either control shRNA or shRNA targeting PERK, isolated from tumors of C57BL/6 mice ( n = 4/group) bearing subcutaneous B16-F10 melanoma and treated with or without anti-PD1 antibody, were evaluated for the frequency of terminally exhausted CD8⁺ T cells (PD1⁺Tim3⁺). The adjacent bar plot summarizes pooled data from four mice per group. * P < 0.05; ** P < 0.01; *** P < 0.005; **** P < 0.0001 ns, nonsignificant ( P > 0.05). The error bar represents the standard deviation (SD). P values are derived from unpaired two-tailed Student’s t test ( A , B ) and one-way ANOVA. .

    Journal: EMBO Reports

    Article Title: S1P-S1PR1 signaling impairs CD8 + T cell metabolism and effector function in tumors

    doi: 10.1038/s44319-026-00734-3

    Figure Lengend Snippet: ( A ) CD8⁺ T cells isolated from either the tumor site or spleen of C57BL/6 mice ( n = 4) bearing YUMM1.7 melanoma were assessed for p-p38 expression. The adjacent bar plot summarizes pooled data from four tumor-bearing mice. ( B ) Intratumoral CD8⁺ T cells from C57BL/6 mice ( n = 4/group) with subcutaneous YUMM1.7 melanoma, treated with vehicle control or p38i, were evaluated for the frequency of terminally exhausted CD8⁺ T cells (PD1⁺Tim3⁺). The adjacent bar plot summarizes pooled data from four mice per group. ( C ) Adoptively transferred Pmel-1 T cells transduced with either control shRNA or shRNA targeting PERK, isolated from tumors of C57BL/6 mice ( n = 4/group) bearing subcutaneous B16-F10 melanoma and treated with or without anti-PD1 antibody, were evaluated for the frequency of terminally exhausted CD8⁺ T cells (PD1⁺Tim3⁺). The adjacent bar plot summarizes pooled data from four mice per group. * P < 0.05; ** P < 0.01; *** P < 0.005; **** P < 0.0001 ns, nonsignificant ( P > 0.05). The error bar represents the standard deviation (SD). P values are derived from unpaired two-tailed Student’s t test ( A , B ) and one-way ANOVA. .

    Article Snippet: Cells were maintained in complete DMEM (Gibco, Thermo Fisher Scientific) supplemented with:10% fetal bovine serum (FBS; Gibco), 1% penicillin–streptomycin (Gibco) For lentiviral production, HEK293T cells were co-transfected with: 15 μg lentiviral expression plasmid encoding S1pr1 shRNA, Eif2ak3 shRNA, or non-targeting scrambled shRNA control (Origene, USA) 10 μg psPAX2 packaging plasmid 5 μg pMD2.G envelope plasmid Transfection was carried out using the CaCl2/HBS precipitation method.

    Techniques: Isolation, Expressing, Control, Transduction, shRNA, Standard Deviation, Derivative Assay, Two Tailed Test

    ( A – D ) C57BL/6 mice ( n = 4 mice/group) with subcutaneously established YUMM1.7 melanoma tumor treated either with vehicle control or p38i, as ( A ) represented schematically, were evaluated for: ( B ) tumor growth, ( C ) frequency of CD8 + T cells at the tumor site, ( D ) the ability of CD8 + T cells from the tumor site to produce different effector cytokines. ( E ) Schematic representation of the ACT protocol where C57BL/6 mice ( n = 4 mice/group) bearing subcutaneous B16-F10 tumors were adoptively transferred with 0.75 × 10⁶ Pmel-1 T cells, followed by treatment with or without anti-PD1 antibody (Clone# RMP1-14; 200 µg/mouse twice weekly), combined with p38i or vehicle control. Mice were subsequently evaluated for: ( F ) tumor growth ( n = 4), ( G ) frequency of Vβ13 + CD8 + T cells at the tumor site ( n = 4), and ( H ) Intracellular expression of effector cytokines in intratumoral Pmel-1 T cells following in vitro restimulation ( n = 4). ( I ) Schematic representation of the ACT protocol where C57BL/6 mice ( n = 4 mice/group) bearing subcutaneous B16-F10 tumors were adoptively transferred with 0.75 × 10⁶ Pmel-1 T cells transduced with either control shRNA (Pmel WT ) or shRNA targeting PERK (Pmel PERK ), followed by treatment with or without anti-PD1 antibody (Clone# RMP1-14; 200 µg/mouse twice weekly). Mice were evaluated for: ( J ) tumor growth ( n = 4), ( K ) frequency of Vβ13 + CD8 + T cells at the tumor site ( n = 4), and ( L ) Intracellular expression of effector cytokines in intratumoral Pmel-1 T cells following in vitro restimulation ( n = 4). * P < 0.05; ** P < 0.01; *** P < 0.005; **** P < 0.0001; ns, nonsignificant ( P > 0.05), the error bar represents the standard deviation (SD). P values are derived from unpaired two-tailed Student’s t test ( C , D ), one-way ANOVA ( G , H , K , L ), and two-way ANOVA test ( B , F , J ). .

    Journal: EMBO Reports

    Article Title: S1P-S1PR1 signaling impairs CD8 + T cell metabolism and effector function in tumors

    doi: 10.1038/s44319-026-00734-3

    Figure Lengend Snippet: ( A – D ) C57BL/6 mice ( n = 4 mice/group) with subcutaneously established YUMM1.7 melanoma tumor treated either with vehicle control or p38i, as ( A ) represented schematically, were evaluated for: ( B ) tumor growth, ( C ) frequency of CD8 + T cells at the tumor site, ( D ) the ability of CD8 + T cells from the tumor site to produce different effector cytokines. ( E ) Schematic representation of the ACT protocol where C57BL/6 mice ( n = 4 mice/group) bearing subcutaneous B16-F10 tumors were adoptively transferred with 0.75 × 10⁶ Pmel-1 T cells, followed by treatment with or without anti-PD1 antibody (Clone# RMP1-14; 200 µg/mouse twice weekly), combined with p38i or vehicle control. Mice were subsequently evaluated for: ( F ) tumor growth ( n = 4), ( G ) frequency of Vβ13 + CD8 + T cells at the tumor site ( n = 4), and ( H ) Intracellular expression of effector cytokines in intratumoral Pmel-1 T cells following in vitro restimulation ( n = 4). ( I ) Schematic representation of the ACT protocol where C57BL/6 mice ( n = 4 mice/group) bearing subcutaneous B16-F10 tumors were adoptively transferred with 0.75 × 10⁶ Pmel-1 T cells transduced with either control shRNA (Pmel WT ) or shRNA targeting PERK (Pmel PERK ), followed by treatment with or without anti-PD1 antibody (Clone# RMP1-14; 200 µg/mouse twice weekly). Mice were evaluated for: ( J ) tumor growth ( n = 4), ( K ) frequency of Vβ13 + CD8 + T cells at the tumor site ( n = 4), and ( L ) Intracellular expression of effector cytokines in intratumoral Pmel-1 T cells following in vitro restimulation ( n = 4). * P < 0.05; ** P < 0.01; *** P < 0.005; **** P < 0.0001; ns, nonsignificant ( P > 0.05), the error bar represents the standard deviation (SD). P values are derived from unpaired two-tailed Student’s t test ( C , D ), one-way ANOVA ( G , H , K , L ), and two-way ANOVA test ( B , F , J ). .

    Article Snippet: Cells were maintained in complete DMEM (Gibco, Thermo Fisher Scientific) supplemented with:10% fetal bovine serum (FBS; Gibco), 1% penicillin–streptomycin (Gibco) For lentiviral production, HEK293T cells were co-transfected with: 15 μg lentiviral expression plasmid encoding S1pr1 shRNA, Eif2ak3 shRNA, or non-targeting scrambled shRNA control (Origene, USA) 10 μg psPAX2 packaging plasmid 5 μg pMD2.G envelope plasmid Transfection was carried out using the CaCl2/HBS precipitation method.

    Techniques: Control, Expressing, In Vitro, Transduction, shRNA, Standard Deviation, Derivative Assay, Two Tailed Test